ロード中...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Chinês |
| 出版事項: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| シリーズ: | Chinese Journal of Lung Cancer |
| 主題: | |
| オンライン･アクセス: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|